Diabetes

Blood Glucose Test Strips Recall – Includes 359 million strips manufactured by Abbott says FDA

Blood Glucose Test Strips Recall – Includes 359 million strips manufactured by Abbott says FDA

Best Syndication News

(Best Syndication News) - The US Food and Drug Administration (FDA) announced a large recall of blood glucose test strips manufactured for Abbott Diabetes Care and were distributed across the United States and Puerto Rico. There are six different brands involved in the recall, and an estimated 359 million test strips could be involved. The blood glucose monitoring units are not involved in the recall. There are 359 different lots of test strips making this a large scale recall.

The test strips could give an inaccurately low blood glucose measurement which could lead the person to increase blood glucose levels unnecessarily or the person could believe they are at the accurate blood glucose levels, when they could actually be running higher than normal. The test strips problem is that they didn't absorb enough blood for the test to complete correctly and the problem could have been made worse with strips which have been exposed to warmer temperatures or have been sitting around for a longer time period. The test strips involved in the recall were manufactured between January and September 2010 and were sold both online and at retail stores, and also at health care facilities.

Reprogrammed Sperm Cells Could Cure Type 1 Diabetes

alt text

(Best Syndication News) Scientists from the Georgetown University Medical Center (GUMC) say that men with type-1 diabetes may be able to grow their own insulin producing cells.

Researchers reported their findings to an audience at the 50th annual meeting of the American Society of Cell Biology conference in Philadelphia. They found that human spermatogonial stem cells (SSCs) extracted from testicular tissue can change into insulin-secreting beta islet cells.

Type 2 Diabetes – Combination of Weight Training and Aerobic Exercise help Lower A1c Levels

Type 2 Diabetes – Combination of Weight Training and Aerobic Exercise help Lower A1c Levels

Best Syndication News

(Best Syndication News) - Both weight training and aerobic exercise combined was helpful for lowering A1c levels in Type 2 Diabetes patients when comparing those that do physical activities. The benefits of lowering glycemic levels wasn't as good with those that did only one type of exercise and not the other. The HART-D trial study was conducted by Timothy S. Church, M.D., M.P.H., Ph.D., of Louisiana State University System, Baton Rouge, Louisiana along with colleagues reported their findings in the November 24th issue of JAMA.

Most scientists will agree that exercise is important for people diagnosed with type 2 diabetes. These researchers wanted to know which exercise, aerobic, resistance (weight training) or both types of exercise would be the most beneficial to a person with type 2 diabetes.

Church and his colleagues conducted the HART-D trial study which had 262 sedentary men and women diagnosed with type 2 diabetes participate either in an aerobic training, resistance weight training, or a combination of both types to see if there would be lower A1c levels. These official name is HbA1c and is a measurement that tells what a persons blood glucose levels averaged over time. The participants were 63 percent women, 47.3 percent were non-white, average age 56 years old, had a HbA1c level of 7.7 percent, had diabetes mellitus diagnosis for 7.1 years.

Less Body Fat for those who eat more Whole Grains instead of Refined Carbohydrates

Less Body Fat for those who eat more Whole Grains instead of Refined Carbohydrates

photo by -Renee Comet courtesy National Cancer Institute PD

(Best Syndication News) - A study found that people who ate multiple servings of whole grain each day and limit the amount of refined carbohydrates, such as white flour or white rice had 10 percent lower visceral body fat volume which is related to cardiovascular disease. The study was published online in the September 29th edition of the The American Journal of Clinical Nutrition.

Visceral adipose tissue is the kind of fat that is associated with a higher risk for cardiovascular disease. So eating whole grains can help to improve your body chemistry and slim the fat around the mid-section where visceral fat tends to accumulate in and around the organs. The fat located under the skin is called the subcutaneous fat which is different.

Previous studies have linked visceral fat in the organs to increased risk for developing metabolic syndrome which includes hypertension, cholesterol levels that are unhealthy, and also insulin resistance. Sometime the metabolic syndrome can develop into cardiovascular disease or into type 2 diabetes, which are both very serious problems.

Type 2 Diabetes Insulin Sensitivity and Lipid Metabolism might be improved Grapefruit Antioxidant Naringin

Type 2 Diabetes Insulin Sensitivity and Lipid Metabolism might be improved Grapefruit Antioxidant Naringin

Watercolor painting of Citrus - Steadman 1921 PD

(Best Syndication News) - Grapefruit and other citrus fruits can contain naringin. The naringin becomes naringenin during digestion which is an antioxidant that researchers believe can help break down fat in the liver and also help to help aid improvements in insulin sensitivity. Type 2 Diabetes develops when insulin resistance sets in and then causes problems in delivering the glucose in the bloodstream to the cells for energy. The research on narningenin was conducted by researchers from the Hebrew University of Jerusalem and Massachusetts General Hospital (MGH). The study will be appearing in this week's issue of the online journal PLoS ONE.

The researchers found that naringenin activates nuclear receptors that help the liver break down fatty acids. They said that the antioxidant worked so well in their research that it could be comparable to prescription drugs such as Fenofibrate, and Rosiglitazone. The researchers said that the antioxidant wasn't studied in humans, but if the naringenin works as well as it did in their preliminary studies it could possibly become a treatment option for hyperlipidemia, type-2 diabetes, and maybe even metabolic syndrome.

Syndicate content
Share/Save/Bookmark

      

Post to Facebook

Important: The material on Best Syndication is for informational purposes only and is not meant to be advice. Authors may have or will receive monetary compensation from the company's product/s mentioned. You should always seek professional advice before making any legal, financial or medical decisions and this website cannot substitute or replace any trained professional consultation.
Use of this site means that you agree to our TERMS OF SERVICE

Advertise On This Site
Copyright © 2006-2015 By Best Syndication All Rights Reserved